| __timestamp | Bausch Health Companies Inc. | Geron Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 2254600000 | 8901000 |
| Thursday, January 1, 2015 | 2645000000 | 9574000 |
| Friday, January 1, 2016 | 2611000000 | 14695000 |
| Sunday, January 1, 2017 | 2548000000 | 8437000 |
| Monday, January 1, 2018 | 2351000000 | 12723000 |
| Tuesday, January 1, 2019 | 2350000000 | 51272000 |
| Wednesday, January 1, 2020 | 2249000000 | 50052000 |
| Friday, January 1, 2021 | 2394000000 | 783000 |
| Saturday, January 1, 2022 | 2364000000 | 868000 |
| Sunday, January 1, 2023 | 2559000000 | 123740000 |
Data in motion
In the ever-evolving landscape of the pharmaceutical industry, understanding cost structures is pivotal. Bausch Health Companies Inc. and Geron Corporation, two prominent players, exhibit stark contrasts in their cost of revenue over the past decade. From 2014 to 2023, Bausch Health's cost of revenue consistently hovered around $2.4 billion, peaking in 2015 with a 15% increase from the previous year. In contrast, Geron Corporation's expenses were significantly lower, averaging around $28 million, with a notable spike in 2023, surging by over 1,300% compared to 2021. This disparity highlights the differing scales and operational strategies of these companies. While Bausch Health maintains a steady expenditure, Geron's fluctuating costs suggest a dynamic approach to its financial management. Such insights are crucial for investors and stakeholders aiming to navigate the complexities of the pharmaceutical sector.
Comparing Cost of Revenue Efficiency: AstraZeneca PLC vs Bausch Health Companies Inc.
Amgen Inc. vs Bausch Health Companies Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Sanofi vs Bausch Health Companies Inc.
Comparing Cost of Revenue Efficiency: GSK plc vs Geron Corporation
Takeda Pharmaceutical Company Limited vs Geron Corporation: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Intra-Cellular Therapies, Inc. vs Geron Corporation
Walgreens Boots Alliance, Inc. vs Geron Corporation: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Halozyme Therapeutics, Inc. vs Bausch Health Companies Inc.
Analyzing Cost of Revenue: Corcept Therapeutics Incorporated and Bausch Health Companies Inc.
SG&A Efficiency Analysis: Comparing Bausch Health Companies Inc. and Geron Corporation
Vericel Corporation vs Geron Corporation: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Geron Corporation vs Travere Therapeutics, Inc.